DXVX (180400) Stock Overview

Dx & Vx Co., Ltd. develops and commercializes molecular diagnostic techniques for various genetic diseases in South Korea. The company offers BAC chip, a gene based microarray to detect numerical and structural abnormalities of chromosomes in embryos for increasing success rate of in vitro fertilization, check health of fetus, diagnose chromosomal abnormalities in children and adults with health problems, detect chromosomal abnormalities in cancer cells, and check chromosomal abnormalities in stem cells. It is also developing reagents for diagnostic tools that are used in the diagnosis of cervical cancer, sexually transmitted infections, and other diseases. The company was formerly known as Cancer Rop Co., Ltd. and changed its name to Dx & Vx Co., Ltd. in January 2022. Dx & Vx Co., Ltd. was founded in 2001 and is based in Seoul, South Korea.